This site is intended for healthcare professionals
News

FDA approves Semglee an insulin glargine injection biosimilar for types 1 and 2 diabetes.- Mylan + Biocon

Read time: 1 mins
Last updated:16th Jun 2020
Published:16th Jun 2020
Condition: Diabetes Types 1 & 2
Type: drug
Register free for full access to medthority.com